Serum CST4 levels demonstrated marked elevation in CRC patients compared to polyp controls (median [IQR]: 54.07 [32.18–91.49] U/mL vs. 37.48 [24.18–49.28] U/mL; P < 0.01). This evidence concerns the gene CST4 and colorectal carcinoma.